A generic cyclosporine development program.
Schroeder
T J
TJ
SangStat Medical Corporation, Menlo Park, California, USA.
Levy
R
R
Pouletty
P
P
First
M R
MR
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001682:Biological Availability; D018592:Cross-Over Studies; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004304:Dosage Forms; D004311:Double-Blind Method; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged
D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine